SC 13G/A: Entera Bio Ltd.

Ticker: ENTX · Form: SC 13G/A · Filed: Aug 20, 2024 · CIK: 1638097

Entera Bio LTD. SC 13G/A Filing Summary
FieldDetail
CompanyEntera Bio LTD. (ENTX)
Form TypeSC 13G/A
Filed DateAug 20, 2024
Risk Levellow
Pages3
Reading Time4 min
Key Dollar Amounts$0.71
Sentimentneutral

Sentiment: neutral

Topics: sc-13g-a

AI Summary

SC 13G/A filing by Entera Bio Ltd..

Risk Assessment

Risk Level: low

FAQ

What type of filing is this?

This is a SC 13G/A filing submitted by Entera Bio LTD. (ticker: ENTX) to the SEC on Aug 20, 2024.

What is the risk level of this SC 13G/A filing?

This filing has been assessed as low risk.

What are the key financial figures in this filing?

Key dollar amounts include: $0.71 (chase up to 179,640 Ordinary Shares, at $0.71 per Ordinary Share, as disclosed in the).

How long is this filing?

Entera Bio LTD.'s SC 13G/A filing is 3 pages with approximately 1,032 words. Estimated reading time is 4 minutes.

Where can I view the full SC 13G/A filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 1,032 words · 4 min read · ~3 pages · Grade level 10.1 · Accepted 2024-08-20 06:01:17

Key Financial Figures

Filing Documents

Item

Item 3. Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (g) x Parent Holding Company or Control Person. This statement is also being filed by Mr. Renat Yliagoyev in the event he could be deemed to be a controlling person of Centillion Fund Inc. as a result of his purchase, as of July 19, 2024, of 100% ownership of Centillion Fund, Inc., which in turn owns all 2,396,953 of the securities reflected herein; provided, however, that (i) the existence of his control of Centillion Fund, Inc is expressly disclaimed and (ii) the filing of this statement shall not be construed as an admission that Mr. Yliagoyev is the beneficial owner of any of the said securities. In addition, Mr. Yliagoyev maintains warrants to purchase up to 179,640 Ordinary Shares, at $0.71 per Ordinary Share, as disclosed in the Issuer’s Form 8-K on December 30, 2023 (the “Warrants”). The Warrants are exercisable for five (5) years from issuance. While the Warrants are not held in the name of Centillion Funds, Inc., and have not been exercised, given that Mr. Yliagoyev may be deemed as a control person, the number of shares he may ultimately be in control of is 2,576,593.

Ownership

Item 4. Ownership (a) Amount Beneficially Owned: See rows 5-9 of cover page of the reporting person. (b) Percent of Class: See row 11 of cover page of each reporting person (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: See row 5 of cover page of each reporting person (ii) Shared power to vote or to direct the vote: See row 6 of cover page of each reporting person and note in Item 4(a) above (iii) Sole power to dispose or to direct the disposition of: See row 7 of cover page of each reporting person (iv) Shared power to dispose or to direct the disposition of: See row 8 of cover page of each reporting person and note in Item 4(a) above

Ownership of Five Percent or Less of a Class

Item 5. Ownership of Five Percent or Less of a Class. Not Applicable

Ownership of more than Five Percent on Behalf of Another Person

Item 6. Ownership of more than Five Percent on Behalf of Another Person. Not applicable Page 3 of 4

Identification and classification of the subsidiary which acquired the security being reported

Item 7. Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person. Not applicable

Identification and classification of members of the group

Item 8. Identification and classification of members of the group. Not applicable

Notice of Dissolution of Group

Item 9. Notice of Dissolution of Group. Not applicable

Certifications

Item 10. Certifications. Not applicable SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: August 13, 2024 /s/ Renat Yliagoyev Renat Yliagoyev Director The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001). Page 4 of 4

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on Read The Filing